Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A comparability study of 5 commercial KRAS tests.

Diagnostic pathology - 16 Apr 2010

Oliner Kelly, Juan Todd, Suggs Sid, Wolf Michael, Sarosi Ildiko, Freeman Daniel J, Gyuris Tibor, Baron Will, Bakker Andreas, Parker Alex, Patterson Scott D

Abstract excerpt

BACKGROUND: Activating mutations in the KRAS gene occur frequently in human tumors, including colorectal carcinomas; most mutations occur in codons 12 and 13. Mutations in KRAS have been associated with poor response to anti-epidermal growth factor receptor antibodies. Therefore, an accurate and readily available analysis of KRAS mutational status is needed. The aim of this study was to evaluate concordance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma
Share to Fixatives
Share to Formaldehyde

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Observer Variation

Share to Paraffin Embedding

Share to ras Proteins

Share to Reagent Kits, Diagnostic

Share to Tissue Fixation

Source

Open in PubMed Open full text

Identifiers

PMID: 20398393
DOI: 10.1186/1746-1596-5-23
PMCID: PMC2879238

Genes

KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A comparability study of 5 commercial KRAS tests.PMID 20398393Read ↗

Performance and Cost Efficiency of KRAS Mutation Testing for Metastatic Colorectal Cancer in Routine Diagnosis: The MOKAECM Study, a Nationwide ExperienceSemantic proximity Read ↗

Performance evaluation comparison of 3 commercially available PCR-based KRAS mutation testing platforms.Semantic proximity Read ↗

A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens.Semantic proximity Read ↗

Multi-Center Evaluation of the Fully Automated PCR-Based Idylla™ KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal CancerSemantic proximity Read ↗

KRAS mutation analysis by PCR: a comparison of two methods.Semantic proximity Read ↗

Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories.Semantic proximity Read ↗

A Multicenter Blinded Study to Evaluate KRAS Mutation Testing Methodologies in the Clinical SettingSemantic proximity Read ↗

Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing.Semantic proximity Read ↗

Key differences between 13 KRAS mutation detection technologies and their relevance for clinical practiceSemantic proximity Read ↗

BRAF mutation testing in solid tumors: a methodological comparison.Semantic proximity Read ↗

KRAS mutation detection in colorectal cancer by a commercially available gene chip array compares well with Sanger sequencing.Semantic proximity Read ↗

KRAS genotyping as biomarker in colorectal cancer: a comparison of three commercial kits on histologic material.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.